Verition Fund Management’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $689K | Buy |
33,871
+15,475
| +84% | +$315K | ﹤0.01% | 2072 |
|
|
2025
Q1 | $334K | Buy |
+18,396
| New | +$334K | ﹤0.01% | 2182 |
|
|
2022
Q2 | – | Sell |
-87,230
| Closed | -$2.97M | – | 2226 |
|
|
2022
Q1 | $2.97M | Buy |
87,230
+33,368
| +62% | +$1.14M | 0.04% | 487 |
|
|
2021
Q4 | $2.08M | Buy |
+53,862
| New | +$2.08M | 0.02% | 583 |
|
|
2021
Q2 | – | Sell |
-133,064
| Closed | -$2.74M | – | 1772 |
|
|
2021
Q1 | $2.74M | Sell |
133,064
-42,475
| -24% | -$875K | 0.03% | 268 |
|
|
2020
Q4 | $3.08M | Buy |
175,539
+7,915
| +5% | +$139K | 0.03% | 215 |
|
|
2020
Q3 | $2.49M | Buy |
+167,624
| New | +$2.49M | 0.05% | 165 |
|